CLOSE

Specials

  • Life Science Compliance
  • March
  • Genomics Europe
  • Bioanalytical Services Europe
  • Sustainable Technologies
  • BioTech Startup APAC
  • Life Science Packaging
  • Europe
  • APAC
  • Bioanalytical Services APAC
  • Life Science Analytics
  • Bioanalytical Services
  • September
  • June
  • BioTech Startups

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
EUROPE
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Life Science Compliance
  • Contributers

Recommended Insights

The Evolving Financial Crime Regulatory...

Robert WALSH, Deputy CCO, AXA Group

The Process And Culture Requirements For...

Greg Bellotti, Vice President IT/CIO, Elementis Global

Making Digital Health A Primary Rather...

Jennifer Briley Christian, Vice President, Clinical...

How Technology Is Revolutionizing...

Margarita Rivera-Santiago, CISSP, CISM, CRISC, CISA...

The Evolving Internet of Things (IoT) in...

Jerry Power, Executive Director, Institute for...

Aligning IT with the Cadence of your Business

William Leonard, ScD, Chief Information Officer, MPI...

Biopharma Start-Ups and the Development of...

Ulrich Geilinger, Venture Capitalist, HBM Partners AG

Data Governance is Relatively New to the...

William Phillips,SVP & CIO,University Health System

The Evolving Financial Crime Regulatory...

Robert WALSH, Deputy CCO, AXA Group

The Process And Culture Requirements For...

Greg Bellotti, Vice President IT/CIO, Elementis Global

Making Digital Health A Primary Rather...

Jennifer Briley Christian, Vice President, Clinical...

How Technology Is Revolutionizing...

Margarita Rivera-Santiago, CISSP, CISM, CRISC, CISA...

The Evolving Internet of Things (IoT) in...

Jerry Power, Executive Director, Institute for...

Aligning IT with the Cadence of your Business

William Leonard, ScD, Chief Information Officer, MPI...

Biopharma Start-Ups and the Development of...

Ulrich Geilinger, Venture Capitalist, HBM Partners AG

Data Governance is Relatively New to the...

William Phillips,SVP & CIO,University Health System

How Technology Enhances The Effectiveness Of Compliance Programs

By Patrik Florencio, SVP and Chief Compliance & Risk Officer, Amicus Therapeutics And Michael Schneider, Executive Director, Global ERM and Compliance Auditing, Amicus Therapeutics
Tweet

For global life science companies, the challenge of maintaining effective oversight and control over dozens of activities taking place simultaneously across multiple jurisdictions can be daunting—especially when such companies rely on paper processes. As anyone who has been audited or investigated knows painfully well, if you can’t prove oversight and control through documentation, then such oversight and control didn’t happen. This underscores the vital importance of documentation and the weakness of paper processes. When it comes time for non-automated compliance programs to demonstrate effectiveness, documentation is often missing because compliance officers across multiple jurisdictions are saving their documentation onto different computer systems or servers, forgetting to scan and upload required documentation, and/or are unable to demonstrate version control. This is where technology can save the day.


At Amicus, we use a single, global, compliance approval system to review and approve activities taking place around the world. So, regardless of whether the activity involves the French business team hiring a physician in France, the Japanese business team conducting an advisory board in Japan, or the US business team sponsoring medical education in the US, all requests for approval are submitted using the exact same online compliance approval system, which we’ve called the Amicus Compliance Engine (ACE). ACE is powered by an out-of-the-box, yet highly configurable, compliance automation software provided by Lextegrity, a leading software firm started by former in-house life sciences compliance and audit professionals. When new submissions are entered into ACE by the business, Amicus compliance officers receive immediate email notifications and can log-on at any time to review those submissions. But the great advantage of this system is that it serves as a single point of control and documentation for the vast majority of global activities requiring compliance approval. Regardless of geographic location, the business must upload into ACE all information regarding the activity and complete the relevant ACE approval form, which means all information related to the submission gets documented in ACE. Likewise, all information related to approval also gets documented in ACE, including compliance officer activities like follow-up questions to submitters, due diligence, and final approval.


But compliance approval systems with an open architecture that are highly customizable are even more valuable. 


In pharmaceuticals, the corporate compliance function typically oversees the activities of the commercial, medical, patient advocacy, and clinical departments. As such, many compliance approval systems focus on controls related to those departments. However, compliance departments are evolving and at many companies are tasked with responsibilities that extend beyond the traditional areas of oversight. For example, a compliance department may be responsible for managing employee-reported conflicts of interest, for conducting due diligence on third parties, for reviewing patient-related activities, and/or for driving the company’s privacy program, including the review of privacy impact assessments under the GDPR. So, the more a compliance approval system can be customized to cover all areas, both traditional and non-traditional, the more valuable it will be as a single point of control and documentation.


Compliance approval systems with an open architecture that are highly customizable are even more valuable


Yet most valuable of all are compliance approval systems that also allow for real-time integration and key data transfer to other systems. For example, at Amicus, ACE is connected to our contract management system. So, once data related to an activity is entered by the business into ACE, the business doesn’t need to re-enter that same information into the contract management system in order to get a contract. Rather, after the activity has been approved in ACE, the data related to that activity is automatically transferred to the contract management system, and out pops a contract, leading to a happy business partner. Not only is this process efficient and user-friendly for the business, but it also serves as an additional compliance control, because the only way for the business to get a contract is to submit the activity in ACE and have it approved by the compliance department.


In sum, technology-based compliance approval systems offer not only a single point of global control and documentation, which is key from a compliance program perspective, but also permit an efficient and user-friendly experience for the business. A true win-win for all.


Weekly Brief

loading
Top 10 Life Science Compliance Solution Companies - 2021
> <
  • Life Science Compliance 2021

    Top Vendors

    Current Issue

Read Also

The Evolving Internet of Things (IoT) in Healthcare

Jerry Power, Executive Director, Institute for Communications Technology Management, University of Southern California
The Evolving Internet of Things (IoT) in Healthcare

Biopharma Start-Ups and the Development of New Drugs

Ulrich Geilinger, Venture Capitalist, HBM Partners AG
Biopharma Start-Ups and the Development of New Drugs

Future Predictive Analytics Solutions need the Right Level of Regulatory Governance

Frank Wang, System Vice President, IDN Decision Support Analytics, Health First
Future Predictive Analytics Solutions need the Right Level of Regulatory Governance

Using Technology to Increase R&D Productivity in the Life Sciences Sector

Dr. Jaqui Hodgkinson, VP-Product Development, Pharma & Life Sciences, Elsevier R&D Solutions
Using Technology to Increase R&D Productivity in the Life Sciences Sector
De-risking the Preclinical Phase of Immunotherapy Drug Development

De-risking the Preclinical Phase of Immunotherapy Drug Development

Ralph Gareus, Director Business Development, The Jackson Laboratory
Methods and Models from Healthcare Apply to Other Enterprises as Well

Methods and Models from Healthcare Apply to Other Enterprises as Well

Dr. Chris Stout, VP - Research & Data Analytics, ATI Physical Therapy

Revolutionizing Genome Editing with CRISPR

Mark Behlke, CSO, Integrated DNA Technologies
Revolutionizing Genome Editing with CRISPR

Revamping Workflow in Pharma Industry with Technology

Bozidar Jovicevic, VP, Global Head of Digital Therapeutics, Sanofi [EPA:SAN]
Revamping Workflow in Pharma Industry with Technology
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://life-science-compliance.lifesciencesreview.com/cxoinsight/how-technology-enhances-the-effectiveness-of-compliance-programs-nwid-295.html